checkmate 649: nivolumab and chemotherapy or ipilimumab in gc/gejc/eac
Published 1 year ago • 153 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:22
3-year follow-up of checkmate 649: nivolumab chemotherapy in gc/gejc/eac
-
4:43
biomarker analyses of the checkmate 649 trial in gc/gejc/eac
-
6:31
checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac
-
2:26
nivo chemo vs chemo as 1l treatment for advanced gc/gejc/eac: 4 year yr follow-up of checkmate 649
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac
-
6:54
checkmate 649: 1l nivo chemotherapy improves os
-
4:47
nivolumab chemotherapy combination treatment: checkmate649 and attraction-4
-
6:23
checkmate 649 3-year follow-up: nivolumab plus chemotherapy for gastric and esophageal cancers
-
1:19
29-month follow-up from checkmate 648: nivolumab combination therapy in escc
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
0:37
45-month checkmate 648 results show nivolumab combos' sustained benefits in escc
-
9:32
checkmate 648: nivolumab plus ipilimumab or nivo plus chemo versus chemo as (1l) treatment for a...
-
1:01
long-term efficacy of nivolumab combinations in advanced escc in checkmate 648
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
3:15
icon: chemotherapy combined with ipilimumab and nivolumab in metastatic hr breast cancer
-
5:56
nivo chemo vs chemo as first-line treatment for advanced gc/gejc/eac
-
4:58
long-term results from checkmate 040: nivolumab ipilimumab in advanced hcc